Back to Archived Journals » Comparative Effectiveness Research » Volume 8

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]

Total article views   HTML views PDF downloads Totals
5,387 Dovepress* 5,387+ 656 6,043
Totals 5,387 656 6,043
*Since 24 January 2018

View citations on Google Scholar